← Return to Glioblastoma (GBM) trials and therapeutic devices (Optune)

Comment receiving replies

Hi Marcy, I found this about the Nativis Voyager
- An early feasibility study of the Nativis Voyager® device in patients with recurrent glioblastoma: first cohort in US https://www.futuremedicine.com/doi/full/10.2217/cns-2018-0013

If you are in Quebec, Canada, then this publication from CADTH (Canadian Agency for Drugs and Technologies in Health)
- Alternating Electric Fields (“TumourTreating Fields”) for the Treatment of Glioblastoma (English) https://www.cadth.ca/dv/ieht/alternating-electric-fields-tumour-treating-fields-treatment-glioblastoma
- Les champs électriques alternatifs (« champs de traitement de la tumeur ») pour le traitement du glioblastome https://www.cadth.ca/fr/vd/ieht-fr/alternating-electric-fields-tumour-treating-fields-treatment-glioblastoma

Jump to this post

Replies to "Hi Marcy, I found this about the Nativis Voyager - An early feasibility study of the..."

Allo Colleen, thank you for your help. It's really appreciated.
The Optune option seems serious to stop the growth of the recurrent GBM. Good news! But at 21 000$ per month for canadien, ouch (!), it is really expensive. That's the reason why I search for another device, maybe Nativis, but the science of Nativis is really different. Optune stop the mitosis. Nativis seems to reactivate the immune system but there's no clinical proof of that Nativis concept.
If you find any other good science information regarding Nativis, please let me know.